NewsPronto

 

ACN Newswire

Read more press releases from ACN Newswire here

Eisai to Launch In-House Developed New Anti-insomnia Drug Dayvigo (Lemborexant) with Indication for Insomnia in Japan

  • Written by ACN Newswire

image

TOKYO, Jul 6, 2020 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has launched its in-house-discovered and developed orexin receptor antagonist DAYVIGO? 2.5 mg, 5 mg, 10 mg tablets (lemborexant) for treatment of insomnia in Japan on July 6, 2020. Eisai received marketing and manufacturing approval for this formulation on January 23,...

Read more: Eisai to Launch In-House Developed New Anti-insomnia Drug Dayvigo (Lemborexant) with Indication...